Related Experiment Video
Updated: Jul 23, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease
1Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Japan.
Abstract:
The aberrant splicing isoform (PS2V), generated by exon 5 skipping of the Presenilin-2 (PS2) gene transcript, is a diagnostic feature of sporadic Alzheimer's disease (AD). We found PS2V is hypoxia-inducible in human neuroblastoma SK-N-SH cells. We purified a responsible trans-acting factor based on its binding to an exon 5 fragment. The factor was identified as the high mobility group A1a protein (HMGA1a; formerly HMG-I). HMGA1a bound to a specific sequence on exon 5, located upstream of the 5' splice site. HMGA1a expression was induced by hypoxia and the protein was accumulated in the nuclear speckles with the endogenous splicing factor SC35. Overexpression of HMGA1a generated PS2V, but PS2V was repressed by cotransfection with the U1 snRNP 70K protein that has a strong affinity to HMGA1a. HMGA1a could interfere with U1 snRNP binding to the 5' splice site and caused exon 5 skipping. HMGA1a levels were significantly increased in the brain tissue from sporadic AD patients. We propose a novel mechanism of sporadic AD that involves HMGA1a-induced aberrant splicing of PS2 pre-mRNA in the absence of any mutations.
Insights
Aberrant splicing of the Presenilin-2 gene (PS2V) is linked to Alzheimer's disease (AD). Hypoxia induces the high mobility group A1a protein (HMGA1a), which causes PS2V by disrupting splicing, offering a new AD mechanism.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Aberrant splicing of the Presenilin-2 (PS2) gene, producing the PS2V isoform, is a hallmark of sporadic Alzheimer's disease (AD).
- The molecular mechanisms driving this aberrant splicing in AD remain largely unknown.
Purpose of the Study:
- To identify the trans-acting factors responsible for hypoxia-induced PS2V generation.
- To elucidate the role of these factors in the pathogenesis of sporadic AD.
Main Methods:
- Hypoxia induction in human neuroblastoma cells (SK-N-SH).
- Purification and identification of a trans-acting factor binding to PS2 exon 5.
- Overexpression studies of identified factor and splicing factors.
- Analysis of HMGA1a levels in brain tissue from sporadic AD patients.
Main Results:
- PS2V splicing is induced by hypoxia in neuronal cells.
- High mobility group A1a protein (HMGA1a) was identified as the hypoxia-inducible factor binding to PS2 exon 5.
- HMGA1a overexpression promotes PS2V formation by interfering with U1 snRNP binding, leading to exon 5 skipping.
- HMGA1a levels are significantly elevated in the brains of sporadic AD patients.
Conclusions:
- HMGA1a is a key mediator of hypoxia-induced aberrant PS2 splicing.
- HMGA1a-driven PS2V generation represents a novel molecular mechanism in sporadic Alzheimer's disease pathogenesis.
- Targeting HMGA1a may offer a therapeutic strategy for sporadic AD.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
Related Concept Videos
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology